Shares of Molina Healthcare, Inc (NYSE:MOH - Get Free Report) have earned an average rating of "Hold" from the seventeen ratings firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $202.4375.
A number of brokerages have recently commented on MOH. Barclays dropped their price target on Molina Healthcare from $184.00 to $180.00 and set an "underweight" rating for the company in a research note on Friday, July 24th. Truist Financial reduced their price objective on Molina Healthcare from $250.00 to $225.00 and set a "hold" rating on the stock in a research report on Friday, July 24th. Weiss Ratings cut Molina Healthcare from a "hold (c-)" rating to a "sell (d+)" rating in a report on Friday, July 24th. Mizuho set a $215.00 target price on Molina Healthcare in a research report on Monday, June 8th. Finally, TD Cowen lifted their price target on Molina Healthcare from $163.00 to $230.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th.
Read Our Latest Research Report on MOH
Molina Healthcare Trading Down 4.4%
MOH opened at $203.13 on Tuesday. The company's 50 day moving average is $211.07 and its 200-day moving average is $178.05. The company has a market cap of $10.60 billion, a P/E ratio of -1,128.44, a PEG ratio of 30.44 and a beta of 0.75. Molina Healthcare has a 1-year low of $121.06 and a 1-year high of $244.89. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.95.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, beating the consensus estimate of $1.39 by $0.12. The business had revenue of $10.87 billion during the quarter, compared to the consensus estimate of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.73%. The firm's revenue was down 4.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.48 EPS. Equities research analysts predict that Molina Healthcare will post 5.29 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the business. Torren Management LLC bought a new stake in Molina Healthcare during the 4th quarter worth approximately $26,000. Physician Wealth Advisors Inc. raised its stake in shares of Molina Healthcare by 1,250.0% during the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company's stock valued at $29,000 after acquiring an additional 200 shares during the last quarter. Quarry LP bought a new position in shares of Molina Healthcare during the fourth quarter valued at $32,000. SJS Investment Consulting Inc. grew its stake in shares of Molina Healthcare by 504.9% in the first quarter. SJS Investment Consulting Inc. now owns 248 shares of the company's stock worth $33,000 after purchasing an additional 207 shares during the last quarter. Finally, Elevation Wealth Partners LLC grew its stake in shares of Molina Healthcare by 118.2% in the second quarter. Elevation Wealth Partners LLC now owns 144 shares of the company's stock worth $33,000 after purchasing an additional 78 shares during the last quarter. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.